Hunan Dahan Interactive Entertainment Culture Media Co., Ltd.

Hunan Erkang Pharmaceutical Co., Ltd. (Stock Code: 300267) was founded in October 2003 and listed on the Shenzhen Stock Exchange on September 27, 2011. The company is located in the picturesque Liuyang Economic and Technological Development Zone. Since its establishment, the company has been engaged in the research, development, production, and sales of pharmaceutical products, mainly including pharmaceutical excipients, active pharmaceutical ingredients, and novel antibiotics.
The company is one of the domestic professional pharmaceutical excipient manufacturers with the most complete varieties and the largest scale, and is one of the few domestic enterprises possessing registration approval documents for both the active pharmaceutical ingredient and finished drug of sulbenicillin sodium, a novel penicillin-class antibiotic.
Erkang Pharmaceutical is a formulator and promoter of domestic pharmaceutical excipient industry standards. Adhering to the business philosophy of "Professionalism achieves the future, quality forges brilliance," the company achieves professional production, serialized varieties, scientific application, and premium services. Meanwhile, with the mission of "Everything for the safety of medicines," the company regards the quality and safety of products such as pharmaceutical excipients as its lifeblood. Leveraging its advantages in the field of pharmaceutical excipients, the company strives to improve the quality level of pharmaceutical excipients, promote the construction of the pharmaceutical excipient standards system, actively develop pharmaceutical excipient products for various formulations, achieve variety scaling and quality standardization, and endeavor to build the company into a leader in China's pharmaceutical excipient industry.

Honors obtained by the company since its listing:
In August 2011, awarded the "Top Ten Pharmaceutical Excipient Brands"
In January 2012, awarded by Forbes: 2012 China's Most Potential Growth Enterprise Board Listed Companies (7th place)
In July 2012, awarded the 2011 Golden Bull Best Entrepreneurial Growth Company (2nd place)
In August 2013, awarded "China Growth Enterprise Board Listed Companies Top 20 by Value" (8th place) and "China Growth Enterprise Board Listed Companies Top Ten Management Teams" (10th place); awarded the 2012 (6th) Pharmaceutical Industry "Top Ten National Brands" title
In February 2014, awarded two honorary titles: "2013 Changsha Top 30 Industrial Enterprises" and "2013 Enterprise with Profits and Taxes Exceeding 100 Million Yuan"